Cardiovascular: Atrial fibrillation (AF) Circulatory System Atrial fibrillation (AF)
Conditions
Interventions
2 groups - a control group given placebo and a study group given sotalol with magnesium.
Preoperative assessment of electrocardiogram (ECG), serum potassium and magnesium levels. ECG
Sponsors
Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: Therapeutic research: All patients admitted for cardiac surgery in The Cardiothoracic centre are potential participants. All the details of the study are explained to the patients and a patient information sheet is given to them. Following this, a proper consent is obtained.
Exclusion criteria
Exclusion criteria: 1. Patients who are in another trial that might have a bearing or influence in outcome in this study 2. Patients undergoing aortic procedure, preoperative atrial fibrillation or second or third degree heart block and patients with preoperative creatinine value of more than 200.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To monitor the frequency of atrial fibrillation following pre-operative treatment with sotalol and magnesium and to determine its efficacy in a large group of cardiac surgery patients. 2. The prevention of Atrial Fibrillation in patients undergoing Cardiac Surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed